Holen Sie sich die Stockscreener-App
9.165
1.24%
-0.135
Schlusskurs vom Vortag:
$9.30
Offen:
$9.06
24-Stunden-Volumen:
410.96K
Relative Volume:
0.37
Marktkapitalisierung:
$489.76M
Einnahmen:
$1.02B
Nettoeinkommen (Verlust:
$-757.20M
KGV:
-0.6209
EPS:
-14.76
Netto-Cashflow:
$-257.90M
1W Leistung:
-7.41%
1M Leistung:
+12.84%
6M Leistung:
+100.55%
1J Leistung:
+2.06%
1-Tages-Spanne:
$8.97
$9.31
1-Wochen-Bereich:
$8.97
$10.10
52-Wochen-Spanne:
$4.02
$12.73
Emergent Biosolutions Inc Stock (EBS) Company Profile
Firmenname
Emergent Biosolutions Inc
Sektor
Telefon
240-631-3200
Adresse
300 PROFESSIONAL DR, GAITHERSBURG, MD
Vergleichen Sie EBS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
EBS
Emergent Biosolutions Inc
|
9.18 | 496.17M | 1.02B | -757.20M | -257.90M | -14.76 |
|
ZTS
Zoetis Inc
|
143.29 | 63.05B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.79 | 43.33B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.17 | 40.43B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.12 | 22.97B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
433.51 | 19.90B | 3.08B | 1.24B | 1.07B | 25.61 |
Emergent Biosolutions Inc Stock (EBS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-30 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-08-22 | Eingeleitet | Rodman & Renshaw | Buy |
| 2024-03-07 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2023-11-20 | Fortgesetzt | JP Morgan | Underweight |
| 2023-08-29 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2023-04-10 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2023-03-17 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2022-11-10 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2022-04-29 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2022-01-20 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2021-11-08 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2021-05-05 | Herabstufung | Argus | Buy → Hold |
| 2021-04-07 | Eingeleitet | The Benchmark Company | Buy |
| 2021-02-24 | Hochstufung | Chardan Capital Markets | Neutral → Buy |
| 2021-02-19 | Herabstufung | Chardan Capital Markets | Buy → Neutral |
| 2021-01-08 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2020-09-14 | Fortgesetzt | JP Morgan | Neutral |
| 2020-07-31 | Bestätigt | Chardan Capital Markets | Buy |
| 2019-09-12 | Eingeleitet | Guggenheim | Buy |
| 2019-09-04 | Hochstufung | Wells Fargo | Market Perform → Outperform |
| 2018-11-02 | Hochstufung | Goldman | Neutral → Buy |
| 2018-08-03 | Bestätigt | Chardan Capital Markets | Buy |
| 2018-06-13 | Eingeleitet | Argus | Buy |
| 2018-04-25 | Herabstufung | Wells Fargo | Outperform → Market Perform |
| 2018-01-24 | Eingeleitet | Goldman | Neutral |
| 2018-01-16 | Bestätigt | Chardan Capital Markets | Buy |
| 2016-06-28 | Bestätigt | Singular Research | Buy |
| 2016-04-15 | Eingeleitet | Chardan Capital Markets | Buy |
| 2016-03-28 | Eingeleitet | Singular Research | Buy |
| 2016-02-19 | Eingeleitet | Wells Fargo | Outperform |
| 2014-05-15 | Eingeleitet | Summer Street Research | Buy |
| 2011-05-31 | Bestätigt | WBB Securities | Strong Buy |
| 2011-01-10 | Bestätigt | Wedbush | Outperform |
| 2010-11-05 | Bestätigt | Wedbush | Outperform |
| 2010-08-18 | Hochstufung | WBB Securities | Buy → Strong Buy |
| 2010-08-06 | Bestätigt | Caris & Company | Buy |
Alle ansehen
Emergent Biosolutions Inc Aktie (EBS) Neueste Nachrichten
What earnings revisions data tells us about Emergent BioSolutions Inc.Insider Selling & Real-Time Price Movement Reports - newser.com
Is Emergent BioSolutions Inc. stock dividend yield sustainableMarket Movers & Long-Term Growth Plans - newser.com
Why Emergent BioSolutions Inc. stock remains resilientShare Buyback & Daily Profit Focused Screening - newser.com
Will Emergent BioSolutions Inc. stock return to pre crisis levelsJuly 2025 Decliners & Breakout Confirmation Alerts - newser.com
Pattern recognition hints at Emergent BioSolutions Inc. upsidePortfolio Return Report & Low Volatility Stock Suggestions - newser.com
How Emergent BioSolutions Inc. stock benefits from tech adoption2025 Key Highlights & Weekly High Return Opportunities - newser.com
Reversal indicators forming on Emergent BioSolutions Inc. stockJuly 2025 Review & Daily Chart Pattern Signals - newser.com
Short interest data insights for Emergent BioSolutions Inc.July 2025 Spike Watch & Expert Approved Momentum Trade Ideas - newser.com
How strong is Emergent BioSolutions Inc. stock balance sheetJuly 2025 Update & Consistent Profit Alerts - newser.com
Emergent BioSolutions Inc. (EBS): Investor Outlook With A 34% Potential Upside - DirectorsTalk Interviews
Emergent Biosolutions (NYSE:EBS) Given "Sell (D)" Rating at Weiss Ratings - MarketBeat
Is Emergent BioSolutions Inc. (ER4) stock dividend growth reliableQuarterly Trade Summary & Real-Time Sentiment Analysis - newser.com
Emergent BioSolutions Inc.'s (NYSE:EBS) Shares Bounce 31% But Its Business Still Trails The Industry - simplywall.st
Emergent BioSolutions to Report Third Quarter 2025 Financial Results on October 29, 2025 - The Manila Times
Emergent BioSolutions Inc. Announces Conference Call for Third Quarter 2025 Financial Results - Quiver Quantitative
Emergent Biosolutions (NYSE:EBS) Stock Price Up 5.3%Still a Buy? - MarketBeat
Emergent Biosolutions (NYSE:EBS) Share Price Crosses Above 200 Day Moving AverageShould You Sell? - MarketBeat
Quantitative breakdown of Emergent BioSolutions Inc. recent moveTrade Ideas & Growth Focused Entry Reports - newser.com
Why Emergent BioSolutions Inc. (ER4) stock is listed among top recommendationsWeekly Market Summary & Free Safe Entry Trade Signal Reports - newser.com
Is Emergent BioSolutions Inc. (ER4) stock a buy during volatile marketsJuly 2025 Opening Moves & Short-Term High Return Ideas - newser.com
Published on: 2025-10-05 04:23:16 - newser.com
Is Emergent BioSolutions Inc. stock a top pick in earnings season2025 Market Sentiment & Fast Moving Trade Plans - newser.com
Relative strength of Emergent BioSolutions Inc. in sector analysisWeekly Trend Summary & Long-Term Capital Growth Ideas - newser.com
How to interpret RSI for Emergent BioSolutions Inc. stockPortfolio Update Report & Weekly Setup with ROI Potential - newser.com
Strategies to average down on Emergent BioSolutions Inc.Portfolio Value Report & AI Powered Market Trend Analysis - newser.com
Multi factor analysis applied to Emergent BioSolutions Inc.CEO Change & Entry Point Strategy Guides - newser.com
Finanzdaten der Emergent Biosolutions Inc-Aktie (EBS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.95%
2.89%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):